← All candidates
One insider buy in the last year — $501.8K in all.
37 filings on record.
OGNOrganon & Co.
NYSE · Healthcare · $3.58B
$13.63
-0.29% · Sep 10
One insider buy in the last year — $501.8K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 1 buy◆ 5 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$3.58B
Float
243.0M
93% public
Short % float
Pro
Price / profit
17.5
Price / future profit
3.8
Price / sales
0.6
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Executive Chair
Cox Carrie Smith
Bought $501.8K on Nov 12 — 65,400 sh @ $7.67, held indirect, 84% of their stake.
1 of 1 position beat the S&P
Congress
▸ Disclosures lag trades by 30–45 days.
1 disclosure12 mo
MemberTradeAmountOwnerTradedFiled
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
32 more transactions on Pro →Context
Earnings · EPS vs forecast
1 of 4 quarters beat
Q2 '26$0.85 act−$0.22
Q1 '26$0.71 act−$0.14
Q4 '25$0.63 act−$0.10
Q3 '25$1.01 act+$0.08
The file stays open
37 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice